{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:47Z","timestamp":1789053167555,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04115-3","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:43:33Z","timestamp":1763811813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative outcomes of neoadjuvant chemotherapy versus upfront surgical resection in osteosarcoma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Abdulrahman","family":"Alaseem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishari","family":"Alanezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almehrij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alanezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alrasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf","family":"Alrefaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alshaygy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Albishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem","family":"AlHashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"4115_CR1","unstructured":"Greenwood AC, Arora RD, Shaikh H. Osteosarcoma (Osteogenic Sarcoma). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"4115_CR2","unstructured":"Pullan JE, Lotfollahzadeh S. Primary Bone Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"4115_CR3","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1002\/cam4.1659","volume":"7","author":"J Wu","year":"2018","unstructured":"Wu J, Sun H, Li J, Guo Y, Zhang K, Lang C, et al. Increased survival of patients aged 0-29 years with osteosarcoma: a period analysis, 1984\u20102013. Cancer Med. 2018;7:3652\u201361. https:\/\/doi.org\/10.1002\/cam4.1659.","journal-title":"Cancer Med"},{"key":"4115_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","volume":"125","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125:229\u201334. https:\/\/doi.org\/10.1002\/ijc.24320.","journal-title":"Int J Cancer"},{"key":"4115_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3109\/0284186X.2016.1156740","volume":"55","author":"JMM Cates","year":"2016","unstructured":"Cates JMM, Schoenecker JG. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: a retrospective cohort study of 153 patients. Acta Oncol (Madr). 2016;55:1036\u20139. https:\/\/doi.org\/10.3109\/0284186X.2016.1156740.","journal-title":"Acta Oncol (Madr)"},{"key":"4115_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcped.2023.100029","volume":"2","author":"R van Ewijk","year":"2023","unstructured":"van Ewijk R, Herold N, Baecklund F, Baumhoer D, Boye K, Gaspar N, et al. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma. EJC Paediatric Oncology. 2023;2:100029. https:\/\/doi.org\/10.1016\/j.ejcped.2023.100029.","journal-title":"EJC Paediatric Oncology"},{"key":"4115_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12938-021-00860-0","volume":"20","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wu Q, Gong X, Liu J, Ma Y. Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online. 2021;20:24. https:\/\/doi.org\/10.1186\/s12938-021-00860-0.","journal-title":"Biomed Eng Online"},{"key":"4115_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ctrv.2006.05.005","volume":"32","author":"A Longhi","year":"2006","unstructured":"Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006;32:423\u201336. https:\/\/doi.org\/10.1016\/j.ctrv.2006.05.005.","journal-title":"Cancer Treat Rev"},{"key":"4115_CR9","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","volume":"33","author":"MS Isakoff","year":"2015","unstructured":"Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33:3029\u201335. https:\/\/doi.org\/10.1200\/JCO.2014.59.4895.","journal-title":"J Clin Oncol"},{"key":"4115_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776\u201390. https:\/\/doi.org\/10.1200\/JCO.2002.20.3.776.","journal-title":"J Clin Oncol"},{"key":"4115_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cancers5020591","volume":"5","author":"K Ando","year":"2013","unstructured":"Ando K, Heymann M-F, Stresing V, Mori K, R\u00e9dini F, Heymann D. Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel). 2013;5:591\u2013616. https:\/\/doi.org\/10.3390\/cancers5020591.","journal-title":"Cancers (Basel)"},{"key":"4115_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00238-8","volume":"7","author":"L-L Ma","year":"2020","unstructured":"Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7:7. https:\/\/doi.org\/10.1186\/s40779-020-00238-8.","journal-title":"Mil Med Res"},{"key":"4115_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"4115_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13193-020-01277-2","volume":"12","author":"A Dharanikota","year":"2021","unstructured":"Dharanikota A, Arjunan R, Dasappa A. Factors affecting prognosis and survival in extremity osteosarcoma. Indian J Surg Oncol. 2021;12:199\u2013206. https:\/\/doi.org\/10.1007\/s13193-020-01277-2.","journal-title":"Indian J Surg Oncol"},{"key":"4115_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jnci\/djae229","volume":"117","author":"MD Danese","year":"2025","unstructured":"Danese MD, Groundland JS. Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma. JNCI J Natl Cancer Inst. 2025;117:611\u20138. https:\/\/doi.org\/10.1093\/jnci\/djae229.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"4115_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/pbc.20580","volume":"47","author":"BD Crompton","year":"2006","unstructured":"Crompton BD, Goldsby RE, Weinberg VK, Feren R, O\u2019Donnell RJ, Ablin AR. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer. 2006;47:255\u20139. https:\/\/doi.org\/10.1002\/pbc.20580.","journal-title":"Pediatr Blood Cancer"},{"key":"4115_CR17","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1002\/cncr.27651","volume":"118","author":"NM Bernthal","year":"2012","unstructured":"Bernthal NM, Federman N, Eilber FR, Nelson SD, Eckardt JJ, Eilber FC, et al. Long\u2010term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high\u2010grade, operable osteosarcoma. Cancer. 2012;118:5888\u201393. https:\/\/doi.org\/10.1002\/cncr.27651.","journal-title":"Cancer"},{"key":"4115_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jso.1142","volume":"78","author":"KR Berend","year":"2001","unstructured":"Berend KR, Pietrobon R, Moore JO, Dibernardo L, Harrelson JM, Scully SP. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection. J Surg Oncol. 2001;78:162\u201370. https:\/\/doi.org\/10.1002\/jso.1142.","journal-title":"J Surg Oncol"},{"key":"4115_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1179\/joc.1995.7.3.230","volume":"7","author":"G Bacci","year":"1995","unstructured":"Bacci G, Ruggieri P, Picci P, Briccoli A, Ferraro A, Ferrari S, et al. Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Chemother. 1995;7:230\u20139. https:\/\/doi.org\/10.1179\/joc.1995.7.3.230.","journal-title":"J Chemother"},{"key":"4115_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/030089168807400408","volume":"74","author":"G Bacci","year":"1988","unstructured":"Bacci G, Avella M, Picci P, Briccoli A, Dallari D, Campanacci M. Metastatic patterns in osteosarcoma. Tumori. 1988;74:421\u20137. https:\/\/doi.org\/10.1177\/030089168807400408.","journal-title":"Tumori"},{"key":"4115_CR21","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00432-016-2210-8","volume":"142","author":"A Angelini","year":"2016","unstructured":"Angelini A, Mavrogenis AF, Trovarelli G, Ferrari S, Picci P, Ruggieri P. Telangiectatic osteosarcoma: a review of 87 cases. J Cancer Res Clin Oncol. 2016;142:2197\u2013207. https:\/\/doi.org\/10.1007\/s00432-016-2210-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4115_CR22","first-page":"1181","volume":"24","author":"W Zhu","year":"2019","unstructured":"Zhu W, Zhu L, Bao Y, Zhong X, Chen Y, Wu Q. Clinical evaluation of neoadjuvant chemotherapy for osteosarcoma. J BUON. 2019;24:1181\u20135.","journal-title":"J BUON"},{"key":"4115_CR23","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.26355\/eurrev_201810_16068","volume":"22","author":"S-P Zhang","year":"2018","unstructured":"Zhang S-P, Li X, Li H, Sun X-H, Yan X-F. Significance of neoadjuvant chemotherapy (NACT) in limb salvage treatment of osteosarcoma and its effect on GLS1 expression. Eur Rev Med Pharmacol Sci. 2018;22:6538\u201344. https:\/\/doi.org\/10.26355\/eurrev_201810_16068.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4115_CR24","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2147\/OTT.S136621","volume":"10","author":"G Yuan","year":"2017","unstructured":"Yuan G, Chen J, Wu D, Gao C. Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study. Onco Targets Ther. 2017;10:2745\u201350. https:\/\/doi.org\/10.2147\/OTT.S136621.","journal-title":"Onco Targets Ther"},{"key":"4115_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/jjco\/hyp057","volume":"39","author":"PK Wu","year":"2009","unstructured":"Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol. 2009;39:514\u201322. https:\/\/doi.org\/10.1093\/jjco\/hyp057.","journal-title":"Jpn J Clin Oncol"},{"key":"4115_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.prp.2016.11.009","volume":"213","author":"W Wang","year":"2017","unstructured":"Wang W, Yang J, Wang Y, Wang D, Han G, Jia J, et al. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution. Pathol Res Pract. 2017;213:119\u201325. https:\/\/doi.org\/10.1016\/j.prp.2016.11.009.","journal-title":"Pathol Res Pract"},{"key":"4115_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/srep38783","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B, Xu M, Zheng K, Yu X. Effect of unplanned therapy on the prognosis of patients with extremity osteosarcoma. Sci Rep. 2016;6:6\u201311. https:\/\/doi.org\/10.1038\/srep38783.","journal-title":"Sci Rep"},{"key":"4115_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/jjco\/hyr138","volume":"41","author":"TI Wang","year":"2011","unstructured":"Wang TI, Wu PK, Chen CF, Chen WM, Yen CC, Hung GY, et al. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy. Jpn J Clin Oncol. 2011;41:1244\u201350. https:\/\/doi.org\/10.1093\/jjco\/hyr138.","journal-title":"Jpn J Clin Oncol"},{"key":"4115_CR29","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/cncr.23340","volume":"112","author":"EL Staals","year":"2008","unstructured":"Staals EL, Bacchini P, Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer. 2008;112:1592\u20139. https:\/\/doi.org\/10.1002\/cncr.23340.","journal-title":"Cancer"},{"key":"4115_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00776-014-0665-5","volume":"20","author":"WS Song","year":"2015","unstructured":"Song WS, Jeon DG, Cho WH, Kong CB, Cho SH, Lee SY. Spontaneous necrosis and additional tumor necrosis induced by preoperative chemotherapy for osteosarcoma: a case\u2013control study. J Orthop Sci. 2015;20:174\u20139. https:\/\/doi.org\/10.1007\/s00776-014-0665-5.","journal-title":"J Orthop Sci"},{"key":"4115_CR31","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1007\/s11999-010-1473-7","volume":"468","author":"P Ruggieri","year":"2010","unstructured":"Ruggieri P, Calabr\u00f2 T, Montalti M, Mercuri M. The role of surgery and adjuvants to survival in pagetic osteosarcoma. Clin Orthop Relat Res. 2010;468:2962\u20138. https:\/\/doi.org\/10.1007\/s11999-010-1473-7.","journal-title":"Clin Orthop Relat Res"},{"key":"4115_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.27792","volume":"66","author":"E Palmerini","year":"2019","unstructured":"Palmerini E, Torricelli E, Cascinu S, Pierini M, De Paolis M, Donati D, et al. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? Pediatr Blood Cancer. 2019;66:1\u20136. https:\/\/doi.org\/10.1002\/pbc.27792.","journal-title":"Pediatr Blood Cancer"},{"key":"4115_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jos.2019.04.008","volume":"25","author":"A Nagano","year":"2020","unstructured":"Nagano A, Matsumoto S, Kawai A, Okuma T, Hiraga H, Matsumoto Y, et al. Osteosarcoma in patients over 50 years of age: multi-institutional retrospective analysis of 104 patients. J Orthop Sci. 2020;25:319\u201323. https:\/\/doi.org\/10.1016\/j.jos.2019.04.008.","journal-title":"J Orthop Sci"},{"key":"4115_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.blo.0000145991.65770.e6","volume":"429","author":"HJ Mankin","year":"2004","unstructured":"Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC, Gebhardt MC. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 2004;429:286\u201391. https:\/\/doi.org\/10.1097\/01.blo.0000145991.65770.e6.","journal-title":"Clin Orthop Relat Res"},{"key":"4115_CR35","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1245\/s10434-015-4414-6","volume":"22","author":"MW Joo","year":"2015","unstructured":"Joo MW, Shin SH, Kang YK, Kawai A, Kim HS, Asavamongkolkul A, et al. Osteosarcoma in Asian populations over the age of 40 years: a multicenter study. Ann Surg Oncol. 2015;22:3557\u201364. https:\/\/doi.org\/10.1245\/s10434-015-4414-6.","journal-title":"Ann Surg Oncol"},{"key":"4115_CR36","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1200\/JCO.2003.08.165","volume":"21","author":"AM Goorin","year":"2003","unstructured":"Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21:1574\u201380. https:\/\/doi.org\/10.1200\/JCO.2003.08.165.","journal-title":"J Clin Oncol"},{"key":"4115_CR37","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/annonc\/3.suppl_2.s23","volume":"3","author":"F Gherlinzoni","year":"1992","unstructured":"Gherlinzoni F, Picci P, Bacci G, Campanacci D. Limb sparing versus amputation in osteosarcoma. Ann Oncol. 1992;3:S23\u20137. https:\/\/doi.org\/10.1093\/annonc\/3.suppl_2.s23.","journal-title":"Ann Oncol"},{"key":"4115_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1445-2197.1997.tb04611.x","volume":"67","author":"PM Ellis","year":"1997","unstructured":"Ellis PM, Tattersall MHN, McCaughan B, Stalley P. OSTEOSARCOMA AND PULMONARY METASTASES: 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION. Aust N Z J Surg. 1997;67:625\u20139. https:\/\/doi.org\/10.1111\/j.1445-2197.1997.tb04611.x.","journal-title":"Aust N Z J Surg"},{"key":"4115_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.52312\/jdrs.2023.902","volume":"34","author":"F Erdo\u011fan","year":"2023","unstructured":"Erdo\u011fan F, \u00c7inka H, Akman B\u00c7, Co\u015fkun HS, Dabak N. Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma. Jt Dis Relat Surg. 2023;34:196\u2013206. https:\/\/doi.org\/10.52312\/jdrs.2023.902.","journal-title":"Jt Dis Relat Surg"},{"key":"4115_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14062024","volume":"14","author":"N Sever","year":"2025","unstructured":"Sever N, \u015eim\u015fek F, Onur \u0130D, Arvas H, Guliyev T, \u015eakalar T, et al. Prognostic factors in high grade osteosarcoma patients who received neoadjuvant therapy and subsequently underwent surgery: data from the Turkish Oncology Group. J Clin Med. 2025;14:2024. https:\/\/doi.org\/10.3390\/jcm14062024.","journal-title":"J Clin Med"},{"key":"4115_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.11648\/j.jctr.20251301.12","volume":"13","author":"L Dotson","year":"2025","unstructured":"Dotson L, Blackburn K, Mand D, Trudeau T, Agarwal R, Ward R. Comparing the outcomes of neoadjuvant versus adjuvant chemotherapy for osteosarcoma patients. J Cancer Treat Res. 2025;13:10\u201322. https:\/\/doi.org\/10.11648\/j.jctr.20251301.12.","journal-title":"J Cancer Treat Res"},{"key":"4115_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0959-8049(00)00362-2","volume":"37","author":"S Weeden","year":"2001","unstructured":"Weeden S, Grimer R, Cannon S, Taminiau AH, Uscinska B. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer. 2001;37:39\u201346. https:\/\/doi.org\/10.1016\/S0959-8049(00)00362-2.","journal-title":"Eur J Cancer"},{"key":"4115_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.arcped.2021.11.019","volume":"29","author":"W Ben Kridis","year":"2022","unstructured":"Ben Kridis W, Ennouri S, Khmiri S, Keskes H, Daoud J, Khanfir A. Prognostic factors and treatment of relapsed osteosarcoma: a monocentric Tunisian retrospective study. Archives de P\u00e9diatrie. 2022;29:287\u201391. https:\/\/doi.org\/10.1016\/j.arcped.2021.11.019.","journal-title":"Archives de P\u00e9diatrie"},{"key":"4115_CR44","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1007\/s11999-014-3759-7","volume":"472","author":"A Takeuchi","year":"2014","unstructured":"Takeuchi A, Lewis VO, Satcher RL, Moon BS, Lin PP. What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res. 2014;472:3188\u201395. https:\/\/doi.org\/10.1007\/s11999-014-3759-7.","journal-title":"Clin Orthop Relat Res"},{"key":"4115_CR45","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/cncr.20214","volume":"100","author":"C Rodriguez-Galindo","year":"2004","unstructured":"Rodriguez-Galindo C, Shah N, McCarville MB, Billups CA, Neel MN, Rao BN, et al. Outcome after local recurrence of osteosarcoma. Cancer. 2004;100:1928\u201335. https:\/\/doi.org\/10.1002\/cncr.20214.","journal-title":"Cancer"},{"key":"4115_CR46","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/cncr.21937","volume":"106","author":"G Bacci","year":"2006","unstructured":"Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy. Cancer. 2006;106:2701\u20136. https:\/\/doi.org\/10.1002\/cncr.21937.","journal-title":"Cancer"},{"key":"4115_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jcot.2012.04.004","volume":"3","author":"A Tiwari","year":"2012","unstructured":"Tiwari A. Current concepts in surgical treatment of osteosarcoma. J Clin Orthop Trauma. 2012;3:4\u20139. https:\/\/doi.org\/10.1016\/j.jcot.2012.04.004.","journal-title":"J Clin Orthop Trauma"},{"key":"4115_CR48","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1186\/s12885-020-07502-z","volume":"20","author":"DR Evans","year":"2020","unstructured":"Evans DR, Lazarides AL, Visgauss JD, Somarelli JA, Blazer DG, Brigman BE, et al. Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National cancer database. BMC Cancer. 2020;20:995. https:\/\/doi.org\/10.1186\/s12885-020-07502-z.","journal-title":"BMC Cancer"},{"key":"4115_CR49","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/os.12702","volume":"12","author":"M Xu","year":"2020","unstructured":"Xu M, Wang Z, Yu X, Lin J, Hu Y. Guideline for limb-salvage treatment of osteosarcoma. Orthop Surg. 2020;12:1021\u20139. https:\/\/doi.org\/10.1111\/os.12702.","journal-title":"Orthop Surg"},{"key":"4115_CR50","doi-asserted-by":"publisher","unstructured":"Biermann JS, Hirbe A, Ahlawat S, Bernthal NM, Binitie O, Boles S, et al. Bone Cancer, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2025;23. https:\/\/doi.org\/10.6004\/jnccn.2025.0017.","DOI":"10.6004\/jnccn.2025.0017"},{"key":"4115_CR51","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","volume":"32","author":"SJ Strauss","year":"2021","unstructured":"Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Bone sarcomas: ESMO\u2013EURACAN\u2013GENTURIS\u2013ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021;32:1520\u201336. https:\/\/doi.org\/10.1016\/j.annonc.2021.08.1995.","journal-title":"Ann Oncol"},{"key":"4115_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100389","volume":"30","author":"T Assi","year":"2021","unstructured":"Assi T, Kattan J, Nassereddine H, Rassy E, Briand S, Court C, et al. Chemotherapy in the management of periosteal osteosarcoma: a narrative review. J Bone Oncol. 2021;30:100389. https:\/\/doi.org\/10.1016\/j.jbo.2021.100389.","journal-title":"J Bone Oncol"},{"key":"4115_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8631237","volume":"2018","author":"CM Chan","year":"2018","unstructured":"Chan CM, Lindsay AD, Spiguel ARV, Gibbs CPJ, Scarborough MT. Periosteal osteosarcoma: a single-institutional study of factors related to oncologic outcomes. Sarcoma. 2018;2018:8631237. https:\/\/doi.org\/10.1155\/2018\/8631237.","journal-title":"Sarcoma"},{"key":"4115_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42047-020-0057-4","volume":"3","author":"YS Zvi","year":"2020","unstructured":"Zvi YS, Singla A, Chou AJ, Tingling J, Yang R, Hoang BH, et al. Upfront surgical resection for primary bone tumors: rationale and potential benefits. Surg Exp Pathol. 2020;3:5. https:\/\/doi.org\/10.1186\/s42047-020-0057-4.","journal-title":"Surg Exp Pathol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04115-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:01:38Z","timestamp":1764244898000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4115"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04115-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"446"}}